Increased prefrontal D2 protein in Tourette syndrome: A postmortem analysis of frontal cortex and striatum

Journal of the Neurological Sciences

Volumn 219, Issue 1-2, 2004, Pages 55-61

  Minzer, Karen ^a   Lee, Olivia ^a   Hong, John J ^a   Singer, Harvey S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dopamine receptors; HPLC; Postmortem tissue; Prefrontal cortex; Semiquantitative immunoblotting; Tourette syndrome

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; NEUROTRANSMITTER; RECEPTOR PROTEIN; SYNAPTOPHYSIN; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; SYNAPTOTAGMIN; SYNTAXIN;

ADULT; ARTICLE; BRAIN TISSUE; CADAVER; CALCULATION; CASE REPORT; CAUDATE NUCLEUS; CONTROLLED STUDY; CORPUS STRIATUM; DATA ANALYSIS; DOPAMINE RELEASE; DOPAMINERGIC ACTIVITY; FEMALE; FRONTAL CORTEX; FRONTAL LOBE; GILLES DE LA TOURETTE SYNDROME; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; MALE; METABOLITE; MONOAMINERGIC SYSTEM; NEUROTRANSMISSION; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN SECRETION; PUTAMEN; QUANTITATIVE ANALYSIS; TISSUE SECTION;

3,4-DIHYDROXYPHENYLACETIC ACID; ADULT; AGED; CORPUS STRIATUM; DOPAMINE; FEMALE; HUMANS; MALE; MIDDLE AGED; PREFRONTAL CORTEX; RECEPTORS, DOPAMINE D2; TOURETTE SYNDROME;

EID: 1642569322     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2003.12.006     Document Type: Article

References (35)

1. Singer H.S., Wendlandt J.T. Neurochemistry and synaptic neurotransmission in Tourette syndrome. Adv. Neurol. 85:2001;163-178.
2. Singer H.S. Neurobiology of Tourette syndrome. Neurol. Clin. 15:1997;357-379.
3. Singer H.S., Szymanski S., Giuliano J., Yokoi F., Dogan A.S., Brasic J.R.et al. Elevated intrasynaptic dopamine release in Tourette's syndrome measured by PET. Am. J. Psychiatry. 159:2002;1329-1336.
4. Singer H.S., Hahn I.H., Moran T.H. Abnormal dopamine uptake sites in postmortem striatum from patients with Tourette's syndrome. Ann. Neurol. 30:1991;558-562.
5. Malison R.T., McDougle C.J., van Dyck C.H., Scahill L., Baldwin R.M., Seibyl J.P.et al. [123I]beta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder. Am. J. Psychiatry. 152:1995;1359-1361.
6. Muller-Vahl K.R., Berding G., Brucke T., Kolbe H., Meyer G.J., Hundeshagen H.et al. Dopamine transporter binding in Gilles de la Tourette syndrome. J. Neurol. 247:2000;514-520.
7. Meyer P., Bohnen N.I., Minoshima S., Koeppe R.A., Wernette K., Kilbourn M.R.et al. Striatal presynaptic monoaminergic vesicles are not increased in Tourette's syndrome. Neurology. 53:1999;371-374.
8. Wolf S.S., Jones D.W., Knable M.B., Gorey J.G., Lee K.S., Hyde T.M.et al. Tourette syndrome: prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding. Science. 273:1996;1225-1227.
9. Wong D.F., Singer H.S., Brandt J., Shaya E., Chen C., Brown J.et al. D2-like dopamine receptor density in Tourette syndrome measured by PET. J. Nucl. Med. 38:1997;1243-1247.
10. Peterson B.S., Staib L., Scahill L., Zhang H., Anderson C., Leckman J.F.et al. Regional brain and ventricular volumes in Tourette syndrome. Arch. Gen. Psychiatry. 58:2001;427-440.
11. Gerard E., Peterson B.S. Developmental processes and brain imaging studies in Tourette syndrome. J. Psychosom. Res. 55:2003;13-22.
12. Fredericksen K.A., Cutting L.E., Kates W.R., Mostofsky S.H., Singer H.S., Cooper K.L.et al. Disproportionate increases of white matter in right frontal lobe in Tourette syndrome. Neurology. 58:2002;85-89.
13. Kates W.R., Frederikse M., Mostofsky S.H., Folley B.S., Cooper K., Mazur-Hopkins P.et al. MRI parcellation of the frontal lobe in boys with attention deficit hyperactivity disorder or Tourette syndrome. Psychiatry Res. 116:2002;63-81.
14. Baumgardner T.L., Singer H.S., Denckla M.B., Rubin M.A., Abrams M.T., Colli M.J.et al. Corpus callosum morphology in children with Tourette syndrome and attention deficit hyperactivity disorder. Neurology. 47:1996;477-482.
15. Peterson B.S., Leckman J.F., Duncan J.S., Wetzles R., Riddle M.A., Hardin M.T.et al. Corpus callosum morphology from magnetic resonance images in Tourette's syndrome. Psychiatry Res. 55:1994;85-99.
16. Peterson B.S., Skudlarski P., Anderson A.W., Zhang H., Gatenby J.C., Lacadie C.M.et al. A functional magnetic resonance imaging study of tic suppression in Tourette syndrome. Arch. Gen. Psychiatry. 55:1998;326-333.
17. Stern E., Silbersweig D.A., Chee K.Y., Holmes A., Robertson M.M., Trimble M.et al. A functional neuroanatomy of tics in Tourette syndrome. Arch. Gen. Psychiatry. 57:2000;741-748.
18. Ziemann U., Tergau F., Netz J., Homberg V. Delay in simple reaction time after focal transcranial magnetic stimulation of the human brain occurs at the final motor output stage. Brain Res. 744:1997;32-40.
19. Moll G.H., Heinrich H., Trott G.E., Wirth S., Bock N., Rothenberger A. Children with comorbid attention-deficit-hyperactivity disorder and tic disorder: evidence for additive inhibitory deficits within the motor system. Ann. Neurol. 49:2001;393-396.
20. Robertson M.M., Banerjee S., Kurlan R., Cohen D.J., Leckman J.F., McMahon W.et al. The Tourette syndrome diagnostic confidence index: development and clinical associations. Neurology. 53:1999;2108-2112.
21. Leckman J.F., Riddle M.A., Hardin M.T., Ort S.I., Swartz K.L., Stevenson J.et al. The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J. Am. Acad. Child Adolesc. Psychiatry. 28:1989;566-573.
22. Swerdlow N.R., Young A.B. Neuropathology in Tourette syndrome: an update. Adv. Neurol. 85:2001;151-161.
23. Singer H.S., Hahn I.H., Krowiak E., Nelson E., Moran T. Tourette's syndrome: a neurochemical analysis of postmortem cortical brain tissue. Ann. Neurol. 27:1990;443-446.
24. Singer H.S., Dickson J., Martinie D., Levine M. Second messenger systems in Tourette's syndrome. J. Neurol. Sci. 128:1995;78-83.
25. Alexander G.E., DeLong M.R., Strick P.L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu. Rev. Neurosci. 9:1986;357-381.
26. DeLong M.R., Crutcher M.D., Georgopoulos A.P. Primate globus pallidus and subthalamic nucleus: functional organization. J. Neurophysiol. 53:1985;530-543.
27. Parent A. Cerebral cortex. Carpenter's Human Neuroanatomy. 1996;864-936 Williams and Wilkins, Baltimore.
28. Grace A.A. Cortical regulation of subcortical dopamine systems and its possible relevance to schizophrenia. J. Neural. Transm. 91:1993;111-134.
29. Gobert A., Rivet J.M., Audinot V., Newman-Tancredi A., Cistarelli L., Millan M.J. Simultaneous quantification of serotonin, dopamine and noradrenaline levels in single frontal cortex dialysates of freely-moving rats reveals a complex pattern of reciprocal auto- and heteroreceptor-mediated control of release. Neuroscience. 84:1998;413-429.
30. Ziemann U., Paulus W., Rothenberger A. Decreased motor inhibition in Tourette's disorder: evidence from transcranial magnetic stimulation. Am. J. Psychiatry. 154:1997;1277-1284.
31. Krimer L.S., Jakab R.L., Goldman-Rakic P.S. Quantitative three-dimensional analysis of the catecholaminergic innervation of identified neurons in the macaque prefrontal cortex. J. Neurosci. 17:1997;7450-7461.
32. Gonzalez-Burgos G., Kroner S., Krimer L.S., Seamans J.K., Urban N.N., Henze D.A.et al. Dopamine modulation of neuronal function in the monkey prefrontal cortex. Physiol. Behav. 77:2002;537-543.
33. Tekin S., Cummings J.L. Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update. J. Psychosom. Res. 53:2002;647-654.
34. Arnsten A.F. Modulation of prefrontal cortical-striatal circuits: relevance to therapeutic treatments for Tourette syndrome and attention-deficit hyperactivity disorder. Adv. Neurol. 2001;333-341.
35. Anderson G.M., Pollak E.S., Chatterjee D., Leckman J.F., Riddle M.A., Cohen D.J. Postmortem analysis of subcortical monoamines and amino acids in Tourette syndrome. Adv. Neurol. 58:1992;123-133.